CFTR GENE MUTATION

Clinical trials for CFTR GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new CFTR GENE MUTATION trials appear

Sign up with your email to follow new studies for CFTR GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

New hope for CF patients who Can't use current drugs

Disease control Recruiting now

This study is testing a new inhaled medication called ARCT-032 for adults with cystic fibrosis who cannot use standard CFTR modulator drugs. Participants will use the inhaler daily for 4 weeks while researchers monitor safety and check if it improves lung function and quality of …

Matched conditions: CFTR GENE MUTATION

Phase: PHASE2 • Sponsor: Arcturus Therapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

CFTR GENE MUTATION

Get alerted when new CFTR GENE MUTATION trials appear

New hope for CF patients who Can't use current drugs